BioNavi-NP: Biosynthesis Navigator for Natural Products

05/26/2021 ∙ by Shuangjia Zheng, et al. ∙ 1

Nature, a synthetic master, creates more than 300,000 natural products (NPs) which are the major constituents of FDA-proved drugs owing to the vast chemical space of NPs. To date, there are fewer than 30,000 validated NPs compounds involved in about 33,000 known enzyme catalytic reactions, and even fewer biosynthetic pathways are known with complete cascade-connected enzyme catalysis. Therefore, it is valuable to make computer-aided bio-retrosynthesis predictions. Here, we develop BioNavi-NP, a navigable and user-friendly toolkit, which is capable of predicting the biosynthetic pathways for NPs and NP-like compounds through a novel (AND-OR Tree)-based planning algorithm, an enhanced molecular Transformer neural network, and a training set that combines general organic transformations and biosynthetic steps. Extensive evaluations reveal that BioNavi-NP generalizes well to identifying the reported biosynthetic pathways for 90 building blocks for 73 approaches. Moreover, BioNavi-NP also shows an outstanding capacity of biologically plausible pathways enumeration. In this sense, BioNavi-NP is a leading-edge toolkit to redesign complex biosynthetic pathways of natural products with applications to total or semi-synthesis and pathway elucidation or reconstruction.



There are no comments yet.


page 1

page 2

page 3

page 4

This week in AI

Get the week's most popular data science and artificial intelligence research sent straight to your inbox every Saturday.